A comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators: results from the prospective randomized multicenter EMPIRIC trial.
about
Value of The Wearable Cardioverter Defibrillator (WCD) as a Bridging-Therapy before Implantation of a Cardioverter Defibrillator (ICD)Design effects for highly clustered count data with varying length of follow-up--applying to the analysis of ICD shocks.A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary prProspective multicenter randomized trial of fast ventricular tachycardia termination by prolonged versus conventional anti-tachyarrhythmia burst pacing in implantable cardioverter-defibrillator patients-Atp DeliVery for pAiNless ICD thErapy (ADVANCEProgramming implantable cardioverter-defibrillators in patients with primary prevention indication to prolong time to first shock: results from the PROVIDE study.[Inappropriate ICD therapies: All problems solved with MADIT-RIT?].Reduction of inappropriate anti-tachycardia pacing therapies and shocks by a novel suite of detection algorithms in heart failure patients with cardiac resynchronization therapy defibrillators: a historical comparison of a prospective database.Design of the Primary Prevention Parameters Evaluation (PREPARE) trial of implantable cardioverter defibrillators to reduce patient morbidity [NCT00279279].2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.Positive Psychotherapy to Improve Autonomic Function and Mood in ICD Patients (PAM-ICD): Rationale and Design of an RCT Currently Underway.Polymorphisms in the GNAS Gene as Predictors of Ventricular Tachyarrhythmias and Sudden Cardiac Death: Results From the DISCOVERY Trial and Oregon Sudden Unexpected Death Study.Early therapy following myocardial infarction: arguments for and against implantable cardioverter-defibrillators.Management of patients receiving implantable cardiac defibrillator shocks: recommendations for acute and long-term patient management.Programming ICDs in the Modern Era beyond Out-of-the Box Settings.How to improve outcomes: should we put more emphasis on programming and medical care and less on patient selection?ICD programming.ICD programming to reduce shocks and improve outcomes.Spinal cord stimulation is safe and feasible in patients with advanced heart failure: early clinical experience.Programming implantable cardioverter/defibrillators and outcomes.Reduction of inappropriate ICD therapies in patients with primary prevention of sudden cardiac death: DECREASE study.Advances in implantable cardioverter defibrillator therapy.Health economic concerns on cardiac rhythm management devices longevity and how to overcome them.Heart Rhythm Society: expert consensus statements-part 1.Sensing and detection in Medtronic implantable cardioverter defibrillators.Antitachycardia pacing programming in implantable cardioverter defibrillator: A systematic review.Clinical course and prognostic relevance of antitachycardia pacing-terminated ventricular tachyarrhythmias in implantable cardioverter-defibrillator patients.Examination of the differential impacts of antitachycardia pacing vs. shock on patient activity in the EMPIRIC study.A new algorithm to reduce inappropriate therapy in the S-ICD system.Mechanisms of inappropriate defibrillator therapy in a modern cohort of remotely monitored patients.Single-chamber ICD, single-zone therapy in primary and secondary prevention patients: the simpler the better?Prognostic significance of atrial arrhythmias in a primary prevention ICD population.Reduction of the inappropriate ICD therapies by implementing a new fuzzy logic-based diagnostic algorithm.Impact of defibrillation test protocol and test repetition on the probability of meeting implant criteria.Driving restrictions in patients with implantable cardioverter defibrillators and pacemakers.Longevity of implantable cardioverter-defibrillators: implications for clinical practice and health care systems.Electrophysiology testing and the National Cardiovascular Data Registry: stimulating, yet inconclusive.Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.Is defibrillation testing still necessary? A decision analysis and Markov model.The use of signal analyses of ventricular tachycardia electrograms to predict the response of antitachycardia pacing in patients with implantable cardioverter-defibrillators.Long-term arrhythmia variability after monomorphic ventricular tachycardia in patients with an implantable cardioverter defibrillator.
P2860
Q28067809-A283CE3F-B597-4BB0-A49A-360ECCCD511EQ31141419-1FE2ABE4-1847-4E3D-B3A5-3EC32B5FC0DAQ33157547-F478F7F1-D532-4428-8C2C-9E0927CBDF80Q33158266-7A950286-BFBA-4B2F-A7CE-86F686B8D6CAQ33163381-B75CE12F-390D-4469-AD82-72D6FE2BF981Q33165644-9C2BFBE3-259D-4BB5-8CAD-56AB175E87A4Q33166757-25A9EDE9-70AE-4BD4-A3BC-DA7D244F6745Q34881384-C9087828-C619-490F-8A8E-B0B80EFE68ABQ36594611-E65EB320-9FEA-4213-8B7D-123120A8ABA0Q36840040-C7DA7312-209C-4FD1-BF9E-25BC9737CBEBQ37556392-191860FC-3B19-40FE-A16A-DCA617929D76Q37749822-8E722A11-63A5-48A9-9152-E3E4CF40682CQ37803046-3C5BA9EC-9E45-4108-A18A-64EF20E7C0B1Q37837975-3E48525E-A708-4218-9B41-AE55154FC246Q38051118-2E6EA6AF-161E-450C-8C55-A10805F9DEEFQ38191070-86D900AE-7AAE-4578-AB0D-192107FAB4F0Q38211070-78DBF3BE-E732-4A0E-AE14-66B78ED85528Q38222862-11A1D604-10B0-44DE-8154-3A83233BFB78Q38364204-98566DD2-9E27-4EA5-B565-B4338DC7DFC8Q38411076-A6AB7C7F-81B2-44A2-9A9B-CC8ACE1BF044Q38665047-22DC6248-76B3-464E-A866-65D8F4AA78A2Q38700354-16316413-C433-414F-940C-3644A8EDAC73Q38920755-B1D8DC08-701D-40FE-ADBD-92DB2FF133B3Q38953685-3BC17C47-F596-4DC9-A6D8-D2DAA3AC773BQ39365813-643A0C96-E62D-4F13-923E-D9F05EE3C4E5Q41424761-1BDC3243-AF8E-4D5A-9C01-D4D324A34015Q41561712-73C9F53E-7697-4CC0-B122-5AD13D7BA80CQ41592906-2B9365EB-2213-444E-BB27-82179CB470F3Q43769568-429AFF63-8617-4D6C-80C5-CFA95D37027DQ43892315-C82735F6-AC41-42C1-9E83-FBAC2DCF7F5CQ44412325-74E4374A-1C3A-4490-97C6-E52B56DCDF85Q44909492-0BC0B9DA-443E-469E-87CB-EAD75BE8B727Q46182628-7E5C1B00-5528-42F4-A789-B08E60BBEE78Q47149520-9BE63EBE-7193-4B7B-B7F9-1DC44A0A0032Q47364003-56CB0C93-BE2C-4245-AEF5-500E3A386754Q47659301-1EE06AC6-CE8D-4AE2-A5B2-342E5B4C0E68Q47681875-73473F53-C4E2-4819-928F-0800B319F2D2Q47890449-763F79A0-0C26-44A8-8F43-F7A7A9FF5248Q48138307-DD6B540E-D990-4B59-8FCA-53F964832452Q51007161-E83BC16E-4C62-40AF-BF46-21002EF632C3
P2860
A comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators: results from the prospective randomized multicenter EMPIRIC trial.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
A comparison of empiric to phy ...... zed multicenter EMPIRIC trial.
@ast
A comparison of empiric to phy ...... zed multicenter EMPIRIC trial.
@en
type
label
A comparison of empiric to phy ...... zed multicenter EMPIRIC trial.
@ast
A comparison of empiric to phy ...... zed multicenter EMPIRIC trial.
@en
prefLabel
A comparison of empiric to phy ...... zed multicenter EMPIRIC trial.
@ast
A comparison of empiric to phy ...... zed multicenter EMPIRIC trial.
@en
P2093
P1476
A comparison of empiric to phy ...... zed multicenter EMPIRIC trial.
@en
P2093
Bruce L Wilkoff
EMPIRIC Trial Investigators
John M Morgan
Kevin T Ousdigian
Laurence D Sterns
Ryan D Wilson
Zengri J Wang
P304
P356
10.1016/J.JACC.2006.03.037
P407
P577
2006-06-22T00:00:00Z